Non-profit research organisation Biohub has released what it claims is an AI-powered "world model" of protein biology that ...
Google DeepMind chief Demis Hassabis believes artificial general intelligence may arrive within the next few years, warning ...
According to the job description, the role involves reasoning about threats that may not yet exist but could emerge rapidly ...
OpenAI is offering up to $445,000 for a new AI safety role focused on risks from self-improving systems as competition for ...
OpenAI has posted a job listing offering nearly half a million annually for a safety researcher tasked with considering risks ...
Brian Gormley covers venture capital and healthcare for The Wall Street Journal.
OpenAI is hiring a researcher for a staggering ₹2.5 to ₹3.7 crore salary to ponder future AI risks, specifically recursive ...
Bill Holdings (BILL) reshuffles exec team with new CPO/CTO and strategy role to accelerate innovation and customer value.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results